Cargando…

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

BACKGROUND: Drug-induced colitis is a known complication of therapies that alter the immune balance, damage the intestinal barrier or disturb intestinal microbiota. Immune checkpoint inhibitors (ICI) directed against cancer cells may result in activated T lymphocyte-induced immune-related adverse ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shivaji, Uday N., Jeffery, Louisa, Gui, Xianyong, Smith, Samuel C. L., Ahmad, Omer F., Akbar, Ayesha, Ghosh, Subrata, Iacucci, Marietta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831976/ https://www.ncbi.nlm.nih.gov/pubmed/31723355 http://dx.doi.org/10.1177/1756284819884196

Ejemplares similares

Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives
por: Majumder, Snehali, et al.
Publicado: (2022)

High-definition-iSCAN virtual chromoendoscopy has high sensitivity and specificity for the diagnosis of eosinophilic esophagitis
por: Gregory, Eustace, et al.
Publicado: (2017)

Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
por: Iacucci, Marietta, et al.
Publicado: (2021)

Diverse Immune Effects of Bovine Colostrum and Benefits in Human Health and Disease
por: Ghosh, Subrata, et al.
Publicado: (2021)

Training methods in optical diagnosis and characterization of colorectal polyps: a systematic review and meta-analysis
por: Smith, Samuel C.L., et al.
Publicado: (2021)

Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy
por: Shivaji, Uday N., et al.
Publicado: (2020)

Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease
por: Smith, Samuel C. L., et al.
Publicado: (2021)

High definition i-SCAN endoscopy with water immersion technique accurately reflects histological severity of celiac disease
por: Iacucci, Marietta, et al.
Publicado: (2016)

Blockade of IL-23: What is in the Pipeline?
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2022)

Emotional state should not be used to differentiate IBD from IBS – Authors' reply
por: Iacucci, Marietta, et al.
Publicado: (2020)

Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study
por: Iacucci, Marietta, et al.
Publicado: (2022)

New endoscopic tools in inflammatory bowel disease
por: Nardone, Olga Maria, et al.
Publicado: (2022)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
por: Wang, Zheng-Hang, et al.
Publicado: (2018)

Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
por: Rajha, Eva, et al.
Publicado: (2019)

Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?
por: Nardone, Olga Maria, et al.
Publicado: (2019)

Tests that now deserve to be more widely adopted in IBD clinical practice
por: Labarile, Nunzia, et al.
Publicado: (2020)

Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy
por: Nardone, Olga Maria, et al.
Publicado: (2023)

The Impact of COVID-19 on Gastrointestinal Endoscopy Training in the United Kingdom
por: Siau, Keith, et al.
Publicado: (2020)

Endoscopic findings of checkpoint inhibitor–induced ileitis with use of the latest advanced endoscopic optical diagnosis: near-focus narrow-band imaging
por: Smith, Samuel C.L., et al.
Publicado: (2019)

Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease
por: Lee, Lik Hang, et al.
Publicado: (2017)

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review
por: Mearns, Elizabeth S, et al.
Publicado: (2018)

Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
por: Yamada, Kentaro, et al.
Publicado: (2021)

Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Khan, Shahab R., et al.
Publicado: (2021)

Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021)

PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis
por: Nardone, Olga Maria, et al.
Publicado: (2022)

Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19
por: Li, Xiao-Zhi, et al.
Publicado: (2021)

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
por: Mao, Ren, et al.
Publicado: (2020)

Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019)

Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
por: Iacucci, Marietta, et al.
Publicado: (2020)

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
por: Badran, Yousef R., et al.
Publicado: (2019)

Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors
por: Zhang, Yifan, et al.
Publicado: (2023)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bai, Xiaoyin, et al.
Publicado: (2021)

Management of adverse events related to checkpoint inhibition therapy
por: Rudzki, Jakob Daniel
Publicado: (2018)

Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy
por: Vani, Vanina, et al.
Publicado: (2020)

Cardiac Adverse Events Related to Immune Checkpoint Inhibitors
por: Gujral, Dorothy M., et al.
Publicado: (2020)

Adverse Events by Sedation Type in Gastrointestinal Endoscopy
por: Kim, Joon Sung, et al.
Publicado: (2017)

Gastrointestinal disorders as immune-related adverse events
por: Balducci, Daniele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l26ep563knpa99tt0l1kjugijb